Cingulate Inc. Contracts & Agreements

92 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Amendment to Cingulate Inc. 2021 Omnibus Equity Incentive Plan
Bonus & Incentive Agreements
Cingulate Inc.
Pharmaceuticals
2025
Master Services Agreement between Indegene, Inc. and Cingulate Therapeutics LLC (May 2025)
Services Agreements
Cingulate Inc.
Pharmaceuticals
2025
Grant Agreement between [Foundation] and Cingulate Therapeutics, LLC for CTx-2103 Development
Funding Agreements
Cingulate Inc.
Pharmaceuticals
2025
Description of Capital Stock and Warrants of [Company Name]
Stock Agreements
Cingulate Inc.
Pharmaceuticals
DE
2025
Promissory Note between Cingulate Inc. and Streeterville Capital, LLC dated December 20, 2024
Note Agreements
Cingulate Inc.
Pharmaceuticals
UT
2024
Note Purchase Agreement between Cingulate Inc. and Streeterville Capital, LLC (December 20, 2024)
Note Agreements
Cingulate Inc.
Pharmaceuticals
UT
2024
Placement Agent Common Stock Purchase Warrant between Cingulate Inc. and H.C. Wainwright & Co., LLC, dated July 1, 2024
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2024
Cingulate Inc. Inducement Offer Letter for Exercise of Common Stock Purchase Warrants (June 28, 2024)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2024
Description of Capital Stock and Warrants of [Company Name]
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
DE
2024
Pre-Funded Common Stock Purchase Warrant between Cingulate Inc. and Werth Family Investment Associates LLC (March 2024)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2024
Pre-Funded Common Stock Purchase Warrant Agreement between Cingulate Inc. and Holder (February 6, 2024)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2024
Series A Common Stock Purchase Warrant Agreement between Cingulate Inc. and Holder (February 6, 2024)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2024
Series B Common Stock Purchase Warrant Agreement between Cingulate Inc. and Holder (February 6, 2024)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2024
Placement Agent Common Stock Purchase Warrant between Cingulate Inc. and H.C. Wainwright & Co., LLC (2026)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2024
Pre-Funded Common Stock Purchase Warrant Agreement between Cingulate Inc. and Werth Family Investment Associates LLC (January 25, 2024)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2024
Pre-Funded Common Stock Purchase Warrant Agreement between Cingulate Inc. and Holder
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2024
Series A Common Stock Purchase Warrant Agreement between Cingulate Inc. and Holder (2024)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2024
Series B Common Stock Purchase Warrant Agreement between Cingulate Inc. and Holder (2024)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2024
Placement Agent Common Stock Purchase Warrant between Cingulate Inc. and H.C. Wainwright & Co., LLC
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2024
Pre-Funded Common Stock Purchase Warrant Agreement between Cingulate Inc. and Holder
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2023
Pre-Funded Common Stock Purchase Warrant Agreement between Cingulate Inc. and Holder (2023)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2023
Series A Common Stock Purchase Warrant Agreement between Cingulate Inc. and Holder
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2023
Series B Common Stock Purchase Warrant Agreement between Cingulate Inc. and Holder
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2023
Placement Agent Common Stock Purchase Warrant Agreement between Cingulate Inc. and Placement Agent (2023)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2023
Pre-Funded Common Stock Purchase Warrant Agreement between Cingulate Inc. and Holder (August 2023)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2023
Cingulate Inc. Series A Common Stock Purchase Warrant Agreement (August 2023)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2023
Series B Common Stock Purchase Warrant Agreement between Cingulate Inc. and Holder (August 2023)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2023
Representative’s Warrant Agreement between Cingulate Inc. and Bancroft Capital, LLC
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
NY
2023
Joint Commercialization Agreement between Indegene, Inc. and Cingulate Therapeutics LLC (March 2023)
Collaboration Agreements
Cingulate Inc.
Pharmaceuticals
2023
Placement Agency Agreement between Cingulate Inc. and Lake Street Capital Markets, LLC and Maxim Group LLC
Underwriting Agreements
Cingulate Inc.
Pharmaceuticals
NY
2023
Common Stock Purchase Warrant Agreement between Cingulate Inc. and Holder (March 2023)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2023
Pre-Funded Common Stock Purchase Warrant Agreement between Cingulate Inc. and Holder (March 2023)
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2023
Nonqualified Stock Option Grant Agreement between Cingulate Inc. and Optionee
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
DE
2022
Description of Capital Stock and Warrants of [Company Name]
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
NY
2022
Common Stock Purchase Warrant Agreement between Cingulate Inc. and CEDE & CO.
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
NY
2021
Warrant Agent Agreement between Cingulate Inc. and Computershare Trust Company
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
2021
Common Stock Purchase Warrant Agreement between Cingulate Inc. and Aegis Capital Corp.
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
NY
2021
Nonqualified Stock Option Grant Agreement between Cingulate Inc. and Optionee
Warrant Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Master Services Agreement between Pharmaceutical Manufacturing Research Services, Inc. and Cingulate Therapeutics, LLC
Services Agreements
Cingulate Inc.
Pharmaceuticals
2021
Amendment to Employment Agreement between Cingulate Therapeutics LLC and Matthew N. Brams (Effective January 1, 2025)
Employment Agreements
Cingulate Inc.
Pharmaceuticals
2025
Guaranty Agreement by Cingulate Therapeutics LLC and Cingulate Works, Inc. for Benefit of Streeterville Capital, LLC
Guaranty Agreements
Cingulate Inc.
Pharmaceuticals
UT
2024
Amendment No. 1 to Cingulate Inc. 2021 Omnibus Equity Incentive Plan
Bonus & Incentive Agreements
Cingulate Inc.
Pharmaceuticals
2024
Securities Purchase Agreement between Cingulate Inc. and Purchasers dated February 2, 2024
Purchase Agreements
Cingulate Inc.
Pharmaceuticals
NY
2024
Note Conversion Agreement among Cingulate Therapeutics LLC, Cingulate Inc., and Werth Family Investment Associates LLC (January 2024)
Note Agreements
Cingulate Inc.
Pharmaceuticals
NY
2024
Employment Agreement between Cingulate Therapeutics LLC and Jennifer L. Callahan (CFO)
Employment Agreements
Cingulate Inc.
Pharmaceuticals
DE
2024
Securities Purchase Agreement between Cingulate Inc. and Purchasers (2024)
Purchase Agreements
Cingulate Inc.
Pharmaceuticals
NY
2024
Amendment to Employment Agreement between Cingulate Therapeutics LLC and Matthew N. Brams
Employment Agreements
Cingulate Inc.
Pharmaceuticals
2024
Amendment to Employment Agreement between Cingulate Therapeutics LLC and Raul R. Silva (December 29, 2023)
Employment Agreements
Cingulate Inc.
Pharmaceuticals
2024
Note Conversion Agreement among Cingulate Therapeutics LLC, Cingulate Inc., and Werth Family Investment Associates LLC
Note Agreements
Cingulate Inc.
Pharmaceuticals
NY
2023
Securities Purchase Agreement between Cingulate Inc. and Purchasers (2023)
Purchase Agreements
Cingulate Inc.
Pharmaceuticals
NY
2023
Securities Purchase Agreement between Cingulate Inc. and Purchasers (2023)
Purchase Agreements
Cingulate Inc.
Pharmaceuticals
NY
2023
Underwriting Agreement between Cingulate Inc. and Bancroft Capital, LLC as Representative of the Underwriters
Underwriting Agreements
Cingulate Inc.
Pharmaceuticals
NY
2023
Securities Purchase Agreement between Cingulate Inc. and Purchaser (August 11, 2023)
Purchase Agreements
Cingulate Inc.
Pharmaceuticals
NY
2023
Amendment to At The Market Offering Agreement between Cingulate Inc. and H.C. Wainwright & Co., LLC (May 2, 2023)
Equity Distribution Agreements
Cingulate Inc.
Pharmaceuticals
2023
Amended and Restated Promissory Note between Cingulate Therapeutics LLC and Werth Family Investment Associates LLC
Note Agreements
Cingulate Inc.
Pharmaceuticals
2023
Purchase Agreement between Cingulate Inc. and Lincoln Park Capital Fund, LLC (April 24, 2023)
Purchase Agreements
Cingulate Inc.
Pharmaceuticals
IL
2023
Registration Rights Agreement between Cingulate Inc. and Lincoln Park Capital Fund, LLC (April 24, 2023)
Registration Rights Agreements
Cingulate Inc.
Pharmaceuticals
IL
2023
Amendment to Employment Agreement between Cingulate Therapeutics LLC and Raul R. Silva (Effective January 1, 2023)
Employment Agreements
Cingulate Inc.
Pharmaceuticals
2023
Securities Purchase Agreement between Cingulate Inc. and Purchasers (March 2023)
Purchase Agreements
Cingulate Inc.
Pharmaceuticals
NY
2023
Master Services Agreement between Societal CDMO, Inc. and Cingulate Therapeutics LLC (October 24, 2022)
Services Agreements
Cingulate Inc.
Pharmaceuticals
KS
2022
Amendment to Employment Agreement between Cingulate Therapeutics LLC and Raul R. Silva (April 2022)
Employment Agreements
Cingulate Inc.
Pharmaceuticals
2022
Promissory Note between Cingulate Therapeutics LLC and Werth Family Investment Associates LLC dated August 9, 2022
Note Agreements
Cingulate Inc.
Pharmaceuticals
2022
Cingulate Inc. Incentive Stock Option Grant Agreement with Optionee
Bonus & Incentive Agreements
Cingulate Inc.
Pharmaceuticals
DE
2022
Cingulate Inc. Underwriting Agreement with Aegis Capital Corp. for Unit Offering
Underwriting Agreements
Cingulate Inc.
Pharmaceuticals
2021
Underwriting Agreement between Cingulate Inc. and Aegis Capital Corp. for Common Stock Offering
Underwriting Agreements
Cingulate Inc.
Pharmaceuticals
2021
Cingulate Inc. Common Stock Underwriting Agreement with Oppenheimer & Co. Inc.
Underwriting Agreements
Cingulate Inc.
Pharmaceuticals
2021
Cingulate Inc. 2021 Omnibus Equity Incentive Plan
Bonus & Incentive Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Employment Agreement between Cingulate Therapeutics LLC and Shane J. Schaffer (Chief Executive Officer)
Employment Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Employment Agreement between Cingulate Therapeutics LLC and Matthew N. Brams
Employment Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Employment Agreement between Cingulate Therapeutics LLC and Laurie A. Myers (Executive Vice President and COO)
Employment Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Employment Agreement between Cingulate Therapeutics LLC and Craig S. Gilgallon (Executive Vice President and General Counsel)
Employment Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Employment Agreement between Cingulate Therapeutics LLC and Louis G. Van Horn
Employment Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Employment Agreement between Cingulate Therapeutics LLC and Raul R. Silva
Employment Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Cingulate Inc. Incentive Stock Option Grant Agreement with Optionee
Bonus & Incentive Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Cingulate Inc. Restricted Stock Unit Award Agreement with Awardee
Equity Distribution Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Cingulate Inc. Restricted Stock Award Agreement with Awardee under 2021 Omnibus Equity Incentive Plan
Equity Distribution Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Agreement and Plan of Merger among Cingulate Therapeutics LLC, Cingulate Inc., and Cingulate Pharma LLC dated August 30, 2021
Merger Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Patent and Know-How License Agreement between BDD Pharma Limited and Cingulate Therapeutics LLC (with DDI)
License Agreements
Cingulate Inc.
Pharmaceuticals
NY
2021
Employment Agreement between Cingulate Inc. and Shane J. Schaffer (Chief Executive Officer)
Employment Agreements
Cingulate Inc.
Pharmaceuticals
NJ
2021
Employment Agreement between Cingulate Inc. and Matthew N. Brams (Executive Vice President and Chief Medical Officer)
Employment Agreements
Cingulate Inc.
Pharmaceuticals
NJ
2021
Employment Agreement between Cingulate Inc. and Laurie A. Myers (Executive Vice President and COO)
Employment Agreements
Cingulate Inc.
Pharmaceuticals
NJ
2021
Employment Agreement between Cingulate Inc. and Craig S. Gilgallon (Executive Vice President and General Counsel)
Employment Agreements
Cingulate Inc.
Pharmaceuticals
NJ
2021
Employment Agreement between Cingulate Inc. and Louis G. Van Horn (Executive Vice President and CFO)
Employment Agreements
Cingulate Inc.
Pharmaceuticals
NJ
2021
Employment Agreement between Cingulate Inc. and Raul R. Silva (Executive Vice President and Chief Science Officer)
Employment Agreements
Cingulate Inc.
Pharmaceuticals
NJ
2021
Indemnification Agreement between Cingulate Inc. and Director or Officer
Indemnification Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Promissory Note between Cingulate Therapeutics, LLC and Matthew Brams dated February 26, 2020
Note Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Promissory Note between Cingulate Therapeutics, LLC and Matthew Brams dated September 30, 2020
Note Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Amendment to Promissory Notes between Matthew Brams and Cingulate Therapeutics LLC (April 28, 2021)
Modification Agreements
Cingulate Inc.
Pharmaceuticals
2021
Promissory Note between Cingulate Therapeutics, LLC and Raul Silva dated July 25, 2020
Note Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Amendment to Promissory Note between Raul Silva and Cingulate Therapeutics LLC (April 19, 2021)
Modification Agreements
Cingulate Inc.
Pharmaceuticals
2021
Promissory Note between Cingulate Therapeutics, LLC and Dresch Inc. dated February 1, 2020
Note Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Amendment to Promissory Note between Cingulate Therapeutics LLC and Edward Dresch (Dresch Inc.)
Modification Agreements
Cingulate Inc.
Pharmaceuticals
2021